Physician profile
Detty James
NPI 1396488649
$1,049.72
in general payments reported to CMS, 2019-2025
12 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $49.09 · 2024: $419 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $278.45 | 2023-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $251.93 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $142.53 | 2022 | |
| Pfizer INC. | $85.84 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $62.42 | 2024 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals LP | $61.80 | 2025 | Wainua |
| Merck Sharp & Dohme LLC | $36.70 | 2024-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $36.60 | 2024-2025 | Eliquis, Camzyos |
| Daiichi Sankyo INC. | $29.70 | 2025 | Injectafer |
| Bridgebio Pharma, INC. | $28.18 | 2025 | Attruby |
| Scpharmaceuticals INC. | $22.25 | 2025 | |
| Irhythm Technologies, INC. | $13.32 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Detty James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.